Founded in 2011 and headquartered in the United States, Xeragenx is at the forefront of the biotechnology industry, with its innovative approach to utilizing Intrinsic Factor. This development holds immense potential in improving protein stability, facilitating oral absorption, and achieving 'Precision Liver Targeting'. Additionally, Intrinsic Factor offers opportunities in high sensitivity analytic tests and imaging, promising to enhance existing tests and introduce new ones.
Despite the lack of specific information regarding the last investment and investors, the ground-breaking work and potential of Xeragenx in the biotechnology industry position it as an attractive prospect for venture capital engagement.
Xeragenx
A biotech company committed to improving global health by “Reinventing B12”
Founded 2011
Saint Louis, United States
1 employees
Biotechnology
Saint Louis, United States
1 employees
Biotechnology
General Information
Get notified when Xeragenx moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Xeragenx
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
United States Market
Biotechnology
About Xeragenx
Taxonomy: Recombinant DNA technology, Drug delivery, Healthcare innovation, Biopharmaceuticals, Intrinsic Factor, Protein stability, Oral absorption, Precision medicine, Diagnostic tests, Imaging technology, Food science, Nutraceuticals, Plant-derived products
No funding data available for Xeragenx yet.
Get notified when Xeragenx raises fundingXeragenx Alternatives & Competitors
Xeragenx vs
Bicara Therapeutics
United States
Pioneering bifunctional antibodies for targeted tumor modulation
IPO
123 employees
Biopharma, Biotechnology
Xeragenx vs
FactorLab, Inc.
United States
Human-centered applications & data science for organizations who expect continuous improvement & inj...
Seed
15 employees
IT, Information Technology
Xeragenx vs
Vicarious
United States
The Vicarious business has been acquired by Intrinsic, a robotics software and AI company at Alphabe...
Series Unknown
130 employees
AI, Robotics
FAQ About Xeragenx
A biotech company committed to improving global health by “Reinventing B12”
Xeragenx was founded in 2011.
Xeragenx is headquartered in Saint Louis, United States.
Xeragenx operates in the following industries: Biotechnology.
Xeragenx has approximately 1 employees.
Top alternatives and competitors to Xeragenx include Bicara Therapeutics, FactorLab, Inc., Vicarious, Akasha Imaging, True North Impact Investments. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Xeragenx and Bicara Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Xeragenx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.